medigraphic.com
ISSN 1405-1710 (Print)

2001, Number 2

<< Back Next >>

Rev Cent Dermatol Pascua 2001; 10 (2)

Congenital ecrine spiroadenoma. Report of a case

Mora RGS, Pérez CS, Navarrete FG

Language: Spanish
References: 19
Page: 80-83
PDF size: 78.95 Kb.


ABSTRACT

Eccrine spiradenoma is an uncommon adnexal skin tumor of the eccrine sweat gland that sometimes can suffer a malignant transformation. There are different clinical patterns and congenital cases are infrequent. We report a congenital eccrine spiradenoma and a review of the literature.


REFERENCES

  1. Amador ME. Tumores de los anexos epidérmicos con diferenciación ecrina. Tesis de Posgrado en Dermatología, Leprología y Micología, México, D.F. 1985-1988.

  2. Stegmaier D, Kersting D. Eccrine spiradenoma. Arch Dermatol 1960; 81: 135-6.

  3. Berghorn B, Munger B, Helwig E. Eccrine spiradenoma. A pharmacologic study. Arch Dermatol 1961; 84: 434-8

  4. Schmoeckel C, Burg G. Congenital spiradenoma. Am J of Dermatopathol 1988; 10: 541-5.

  5. Noto G, Bongiorno M. Multiple nevoid spiradenomas. Am J Dermatopathol 1994;16: 280-84.

  6. Wright S, Ryan J. Multiple familial eccrine spiradenoma with cylindroma. Acta Dermato Venearol 1990; 70: 79-82

  7. Cabrera H, Abulafia J. Presentación de tres casos de espiradenoma ecrino múltiple, uno con transformación maligna. Arch Argent Dermat 1999; 49: 209-14.

  8. Jamshidi M, Nowak A. Giant Malignant Eccrine Spiradenoma of the Scalp. Dermatol Surg 1999; 25: 45-8.

  9. Del Pino M, Febrer M. Tumor doloroso en pabellón auricular. Piel 1997; 12: 40-2.

  10. Fitzpatrick T. Dermatology in General Medicine. USA. Fifth edition, 1999; 894-97.

  11. Martín Pascual A, Morán M. Espiradenoma ecrino gigante. Acta Dermo Sifiliograf 1980; may-jun.

  12. Elder D et al. Lever´s histopathology of the skin. Philadelphia. Eigtht edition, 1997; 783-85.

  13. Watanabe S, Hirose M. Immunohistochemical analysis of cytokeratin expression in Eccrine spiradenoma: similarities to the transitional portions between secretory segments and coiled ducts of eccrine glands. Br J Dermatol 1994; 131: 799-807.

  14. Eckert FA, de Viragh P. Coexpression of cytokeratin and vimentin intermediate filaments in benign and malignant sweat gland tumors. J Cutan Pathol 1994; 140-150.

  15. Ishihara M, Mehregan D. Staining of eccrine and apocrine neoplasms and metastasic adenocarcinoma with IKH-4, a monoclonal antibody for the eccrine gland. J Cutan Pathol 1998; 25: 100-105.

  16. Michal M. Spiradenoma associated with apocrine adenoma component. Pathology, Research & Practice 1996; 192: 1135-9. Abstract.

  17. Giménez A. Tumores cutáneos dolorosos. Piel 1993; 284-90.

  18. Varsa E, Jordan S. Fine needle aspiration cytology of malignant spiradenoma arising in the congenital eccrine spiradenoma. Acta Cytologica 1990; 34: 275-7. Abstract.

  19. Biernat W, Kordek R, Wozniak L. Over-expression of p53 protein as an indicator of the malignant transformation in spiradenoma. Histopathology 1995; 26: 439-43.




2020     |     www.medigraphic.com